HENDERSON MICHAEL THOMAS 4
4 · Apogee Therapeutics, Inc. · Filed Jan 6, 2026
Insider Transaction Report
Form 4
HENDERSON MICHAEL THOMAS
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2026-01-02+253,016→ 253,016 totalExercise: $75.78Exp: 2036-01-02→ Common Stock (253,016 underlying)
Footnotes (1)
- [F1]This option represents the right to purchase 253,016 shares of the Issuer's common stock, which will vest in forty-eight equal monthly installments over a four-year period from the date of grant, subject to the Reporting Person's continued service to the Issuer.